Analysed CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) News Sources
Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference
15-03-2026
marketbeat.com
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
13-03-2026
yahoo.com
Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
05-03-2026
yahoo.com
Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
03-03-2026
yahoo.com
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus
02-03-2026
yahoo.com
Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year?
04-02-2026
yahoo.com
Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions
27-01-2026
yahoo.com
Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock?
31-12-2025
yahoo.com
Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?
31-12-2025
yahoo.com
What is the current price of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The current price of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is $12.79.
CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) absolute price change since previous trading day?
The absolute price change of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) since the previous trading day is $-0.08.
CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) percentage price change since previous trading day?
The percentage price change of CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) since the previous trading day is -0.6216%.
What is the most recent average sentiment score for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The most recent average sentiment score for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)?
The most recent sentiment for CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ) is .
SEC-8K** Filing Available For CONTINEUM THERAPEUTICS INC-A (CTNM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.